DRUG GUIDELINE

Iron Polymaltose Infusion
SCOPE (Area): Acute, Sub Acute
SCOPE (Staff): Medical, Nursing, Midwifery, Pharmacy
Printed versions of this document SHOULD NOT be considered up to date / current


Exclusions

Paediatrics (seek Paediatrician advice).


Preamble

See Appendix 1 for full version of this Drug Guideline!


Related Documents

CPP0542 - Drugs Used In The Dialysis Unit
SOP0001 - Principles Of Clinical Care


References

“Iron Polymaltose (Total Body Dose) Infusion� Bayside Health May 2008
“Safety of iron polymaltose given as a total dose iron infusion� (E. Newnham, I. Ahmad, A. Thornton and P.R. Gibson) Internal Medicine Journal 36 (2006) 672-674.
Alfred Health (2013, February). Iron Polymaltose (Total Body Dose) Rapid Infusion Drug Guideline. Alfred Health.
Monash Health (2013, July). Iron Polymaltose (Intravenous Infusions). Monash Health.
Rossi, S. (2013, July). Australian Medicines Handbook. Retrieved September 4, 2013, from
South Australian Government (2014, June). South Australian Perinatal Practice Guidelines – Iron Infusion. South Australian Government.
The Royal College of Pathologists from Australasia (2013, May). Iron Studies Standardised Reporting Protocol – First Edition .The Royal College of Pathologists from Australasia.
The Society of Hospital Pharmacists of Australia. 2011. Australian Injectable Drugs Handbook (5th ed.). Collingwood: The Society of Hospital Pharmacists of Australia.
Therapeutic Guidelines Limited. (2010, June). Antibiotic Guidelines. Retrieved December 2, 2013, from
Therapeutic Guidelines Limited. (2011, February). Gastrointestinal Guideline. Retrieved September 11, 2013, from
Thomson Reuters. (2013). Micromedex 2.0. Retrieved September 11, 2013, from
UBM Medica. (2013, September). MIMS Online, Ferrosig® product information. Retrieved September 4, 2013, from
UBM Medica. (2013, September). MIMS Online, Ferrum H® product information. Retrieved September 4, 2013, from
UpToDate, Inc. (2013) UpToDate, Drug Interaction section. Retrieved September 4, 2013, from


Appendix

Appendix 1 - Iron polymaltose intravenous infusion



Reg Authority: Medication Safety & Governance Committee (MSGC) Date Effective: 27/05/2019
Review Responsibility: Director - Pharmacy Date for Review: 28/05/2023
Iron Polymaltose Infusion - DRG0018 - Version: 5 - (Generated On: 10-07-2023 05:44)